BOSTON, Jan. 30, 2020 – Biofourmis, a fast-growing global leader in digital therapeutics that powers personally predictive care, and ImagineMIC™ announced a partnership agreement today to drive improved outcomes and lower healthcare costs for patients with chronic conditions. ImagineMIC™ is a revolutionary medical device company that delivers chronic care management through remote monitoring services and HIPAA-compliant technology.

The first phase of the collaboration includes integrating Biofourmis’ artificial intelligence (AI)-powered, FDA-cleared RhythmAnalytics® with ImagineMIC’s remote management technology, which is monitored by clinicians located in the ImagineMIC™ Monitoring Intervention Center (MIC) in New York State. RhythmAnalytics®, part of Biofourmis’ Biovitals® Platform, uses enhanced deep learning architecture to detect dozens of cardiac arrhythmias.

RhythmAnalytics® will provide clinical decision support for the board-certified emergency physicians, physician assistants, nurse practitioners and specialty-trained registered nurses in the MIC who perform around-the-clock monitoring of thousands of patients with chronic conditions who are in skilled nursing facilities (SNFs) and subacute care programs.
“This is a scalable partnership that is starting with cardiology, which could ultimately be applied to a number of chronic conditions and therapeutic areas in various care settings by leveraging various modules within the Biovitals® Platform for those applications,” said Kuldeep Singh Rajput, CEO of Biofourmis.

By leveraging a collaborative, integrated approach to telemedicine that includes real-time streaming of hemodynamic data from a wearable sensor and two-lead ECG, the technology that ImagineMIC™ is based on has supported a readmission rate of only 6% for patients with congestive heart failure (CHF), compared to state and national readmission rate averages of about 27% (according to audited results from a pilot program conducted in New York State involving more than 1,000 patients over three years). ImagineMIC’s wearables provide real-time data on patients’ respiratory rate, oxygen levels and heart rate; and Bluetooth streams report blood pressure, blood glucose and weight.

“We expect to continue improving on these already impressive outcomes by combining ImagineMIC’s newer version of the device with the power of RhythmAnalytics® and the Biovitals® Platform,” Rajput said. “The result will be powerful clinical decision support that will enable the healthcare professionals who remotely monitor patients in the MIC to better utilize their time and skills to design interventions with on-site clinicians and focus on the highest need patients.”

Patient Monitors Homepage